• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰国临床样本中分离出的[具体内容缺失]与[具体内容缺失]的共存情况 。

The Co-Existence of and in Isolated from Clinical Samples in Thailand.

作者信息

Nobthai Panida, Ruekit Sirigade, Peerapongpaisarn Dutsadee, Sukhchat Prawet, Swierczewski Brett E, Ruamsap Nattaya, Lertsethtakarn Paphavee

机构信息

Department of Bacterial and Parasitic Diseases, Walter Reed Army Institute of Research-Armed Forces Research Institute of Medical Sciences (WRAIR-AFRIMS), Bangkok 10400, Thailand.

Queen Sirikit Naval Hospital, Chonburi 20180, Thailand.

出版信息

Antibiotics (Basel). 2025 Jun 10;14(6):596. doi: 10.3390/antibiotics14060596.

DOI:10.3390/antibiotics14060596
PMID:40558186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12189599/
Abstract

The emergence of colistin resistance poses a significant threat to its efficacy as a last-line treatment against multidrug-resistant Gram-negative bacterial infections. In this study, 178 multi-drug resistant (MDR) isolates collected from clinical samples at Queen Sirikit Naval Hospital, Chonburi, Thailand, were evaluated for colistin resistance. Of these, six were identified as gene carriers, mediating colistin resistance. Specifically, was detected in three isolates, was detected in one isolate, and and were detected in two isolates, designated AMR-0220 and AMR-0361. Whole-genome sequencing and bioinformatics analysis revealed that AMR-0220 and AMR-0361 belonged to ST410 and ST617 lineages, respectively. Both isolates carried multiple plasmids, with located on an IncX4-type plasmid that is closely related to previously reported -carrying IncX4 plasmids. In contrast, was identified on distinct plasmid backbones: an IncFIB-type plasmid in AMR-0220 and an IncFII-type plasmid in AMR-0361. Overall, our findings demonstrate that the genes found in isolates in this region are located on different mobile genetic elements, indicating the potential for a widespread dissemination of colistin resistance among Gram-negative bacteria throughout Thailand's healthcare system.

摘要

黏菌素耐药性的出现对其作为治疗多重耐药革兰氏阴性菌感染的最后一线药物的疗效构成了重大威胁。在本研究中,对从泰国春武里诗丽吉王后海军医院的临床样本中收集的178株多重耐药(MDR)菌株进行了黏菌素耐药性评估。其中,有6株被鉴定为介导黏菌素耐药性的基因携带者。具体而言,在3株菌株中检测到了 ,在1株菌株中检测到了 ,在2株分别命名为AMR-0220和AMR-0361的菌株中检测到了 和 。全基因组测序及生物信息学分析表明,AMR-0220和AMR-0361分别属于ST410和ST617谱系。这两株菌株均携带多个质粒, 位于一个IncX4型质粒上,该质粒与先前报道的携带 的IncX4质粒密切相关。相比之下, 在不同的质粒骨架上被鉴定出来:在AMR-0220中为IncFIB型质粒,在AMR-0361中为IncFII型质粒。总体而言,我们的研究结果表明,该地区分离出的菌株中发现的 基因位于不同的可移动遗传元件上,这表明黏菌素耐药性在泰国整个医疗系统的革兰氏阴性菌中存在广泛传播的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcfc/12189599/5cfe0fefe92b/antibiotics-14-00596-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcfc/12189599/5cfe0fefe92b/antibiotics-14-00596-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcfc/12189599/5cfe0fefe92b/antibiotics-14-00596-g001a.jpg

相似文献

1
The Co-Existence of and in Isolated from Clinical Samples in Thailand.泰国临床样本中分离出的[具体内容缺失]与[具体内容缺失]的共存情况 。
Antibiotics (Basel). 2025 Jun 10;14(6):596. doi: 10.3390/antibiotics14060596.
2
Comparative study of mcr-10 plasmids in Enterobacter spp. with the mcr-10_ter locus from wastewater and clinical samples: Implications for antimicrobial resistance and fitness.具有来自废水和临床样本的mcr-10_ter基因座的肠杆菌属中mcr-10质粒的比较研究:对抗菌药物耐药性和适应性的影响
J Glob Antimicrob Resist. 2025 May 28;44:40-48. doi: 10.1016/j.jgar.2025.05.021.
3
Epidemiological and genomic characteristics of global -positive isolates.全球阳性分离株的流行病学和基因组特征。
Front Microbiol. 2023 Jan 18;13:1105401. doi: 10.3389/fmicb.2022.1105401. eCollection 2022.
4
First report of an Enterobacter cloacae ST837 resistant to cefiderocol co-harbouring bla and mcr-4.3 resistance genes in Italy.意大利首次报告一株携带bla和mcr - 4.3耐药基因且对头孢地尔耐药的阴沟肠杆菌ST837。
J Glob Antimicrob Resist. 2025 May;42:37-41. doi: 10.1016/j.jgar.2025.01.023. Epub 2025 Feb 11.
5
Occurrence of mcr-1.1-producing Escherichia coli in clinical settings in Tunisia.突尼斯临床环境中产生mcr-1.1的大肠杆菌的出现情况。
J Glob Antimicrob Resist. 2025 Sep;44:149-151. doi: 10.1016/j.jgar.2025.06.011. Epub 2025 Jun 21.
6
Distinct adaptation and epidemiological success of different genotypes within serovar Dublin.都柏林血清型内不同基因型的独特适应性和流行病学成功情况。
Elife. 2025 Jun 25;13:RP102253. doi: 10.7554/eLife.102253.
7
Global prevalence and molecular epidemiology of mcr-mediated colistin resistance in Escherichia coli clinical isolates: a systematic review.全球临床分离大肠杆菌中介导粘菌素耐药的 mcr 流行状况及分子流行病学:系统综述
J Glob Antimicrob Resist. 2022 Jun;29:444-461. doi: 10.1016/j.jgar.2021.10.022. Epub 2021 Nov 14.
8
High prevalence of carbapenem-resistant Escherichia coli ST410 from clinical isolates in Weifang, China.中国潍坊临床分离株中耐碳青霉烯类大肠杆菌ST410的高流行率。
Acta Microbiol Immunol Hung. 2025 Jun 18;72(2):99-105. doi: 10.1556/030.2025.02624. Print 2025 Jun 20.
9
Antimicrobial resistance and phylogenetic lineages of KPC-2-producing blood-borne subsp. from Kolkata, India during 2015-2024: Emergence of subsp. with , , and triple carbapenemases.2015年至2024年期间来自印度加尔各答的产KPC-2血源亚种的抗菌药物耐药性和系统发育谱系:具有NDM-1、IMP-1和VIM-2三重碳青霉烯酶的亚种的出现。
Microbiol Spectr. 2025 Jun 12:e0012625. doi: 10.1128/spectrum.00126-25.
10
A Systematic Review on the Occurrence of Antimicrobial-Resistant in Poultry and Poultry Environments in Bangladesh between 2010 and 2021.2010 年至 2021 年期间孟加拉国禽肉和禽环境中出现的抗微生物耐药性的系统评价
Biomed Res Int. 2023 Feb 1;2023:2425564. doi: 10.1155/2023/2425564. eCollection 2023.

本文引用的文献

1
Characteristics and genomic epidemiology of colistin-resistant Enterobacterales from farmers, swine, and hospitalized patients in Thailand, 2014-2017.2014-2017 年泰国农民、猪和住院患者中产碳青霉烯酶肠杆菌科细菌的特征和基因组流行病学。
BMC Infect Dis. 2023 Aug 28;23(1):556. doi: 10.1186/s12879-023-08539-8.
2
Exploring the epidemiology of mcr genes, genetic context and plasmids in Enterobacteriaceae originating from pigs and humans on farms in Thailand.探究泰国农场猪源和人源肠杆菌科细菌中 mcr 基因、遗传环境和质粒的流行情况。
J Antimicrob Chemother. 2023 Jun 1;78(6):1395-1405. doi: 10.1093/jac/dkad097.
3
Comparative genomic analysis of Colistin resistant Escherichia coli isolated from pigs, a human and wastewater on colistin withdrawn pig farm.
从停用人用粘菌素猪养殖场的猪、人和废水分离的粘菌素耐药大肠杆菌的比较基因组分析。
Sci Rep. 2023 Mar 29;13(1):5124. doi: 10.1038/s41598-023-32406-w.
4
Epidemiological and genomic characteristics of global -positive isolates.全球阳性分离株的流行病学和基因组特征。
Front Microbiol. 2023 Jan 18;13:1105401. doi: 10.3389/fmicb.2022.1105401. eCollection 2022.
5
Plasmidome in mcr-1 harboring carbapenem-resistant enterobacterales isolates from human in Thailand.泰国人类携带 mcr-1 的碳青霉烯类耐药肠杆菌科分离株的质粒组。
Sci Rep. 2022 Nov 9;12(1):19051. doi: 10.1038/s41598-022-21836-7.
6
Introducing the Bacterial and Viral Bioinformatics Resource Center (BV-BRC): a resource combining PATRIC, IRD and ViPR.推出细菌和病毒生物信息学资源中心(BV-BRC):一个整合 PATRIC、IRD 和 ViPR 的资源。
Nucleic Acids Res. 2023 Jan 6;51(D1):D678-D689. doi: 10.1093/nar/gkac1003.
7
Co-occurrence of mcr-2 and mcr-3 genes on chromosome of multidrug-resistant Escherichia coli isolated from healthy individuals in Thailand.泰国健康个体分离的多重耐药性大肠杆菌染色体上 mcr-2 和 mcr-3 基因的共存。
Int J Antimicrob Agents. 2022 Oct;60(4):106662. doi: 10.1016/j.ijantimicag.2022.106662. Epub 2022 Aug 22.
8
Molecular characterization of multidrug-resistant ESKAPEE pathogens from clinical samples in Chonburi, Thailand (2017-2018).泰国春武里府临床样本中 ESKAPEE 多重耐药病原体的分子特征(2017-2018 年)。
BMC Infect Dis. 2022 Aug 17;22(1):695. doi: 10.1186/s12879-022-07678-8.
9
Whole genome sequence of EC16, a bla-, bla-, and fosA3-coproducing Escherichia coli ST167 clinical isolate from China.中国产 bla、bla 和 fosA3 共产型大肠杆菌 ST167 临床分离株 EC16 的全基因组序列。
J Glob Antimicrob Resist. 2022 Jun;29:296-298. doi: 10.1016/j.jgar.2022.04.001. Epub 2022 Apr 10.
10
Genomic characterisation of an mcr-1 and mcr-3-producing Escherichia coli strain isolated from pigs in France.从法国猪体内分离出的一株产mcr-1和mcr-3的大肠杆菌的基因组特征分析
J Glob Antimicrob Resist. 2022 Mar;28:174-179. doi: 10.1016/j.jgar.2022.01.014. Epub 2022 Jan 24.